Merck(MRK) has agreed to acquire Cidara Therapeutics, Inc. in a deal valued at up to $430 million, a strategic move that strengthens the pharmaceutical giant’s position in the antifungal drug market as global infections rise. Announced on November 14, 2025, […]
MicroStrategy shares have continued their downward trajectory in November 2025, declining 30.49% year-to-date and slipping below the value of its Bitcoin holdings for the first time since early 2024. The software company’s stock closed at $208.54 on November 14, 2025,
Cisco shares surged 7% in pre-market trading on November 13, 2025, following a first-quarter fiscal 2026 earnings report that exceeded Wall Street expectations and highlighted robust demand for AI networking equipment. The San Jose-based networking giant reported revenue of $14.9
Portable mortgages are gaining traction in 2025 as homebuyers face persistent high interest rates and a challenging housing market, with major lenders like Wells Fargo, Chase, and Rocket Mortgage introducing new products that allow borrowers to transfer their existing loan
Sonder Holdings Inc., the innovative short-term rental company that once promised to revolutionize hotel stays with app-based access and tech-savvy amenities, has abruptly ceased operations and plans to file for Chapter 7 bankruptcy liquidation. The announcement, made on November 10,
Circle(CRCL) reported robust third-quarter 2025 results on November 12, 2025, with revenue surging 66% year-over-year to $214.1 million, driven by a 90% increase in USDC stablecoin circulation to $61.3 billion. The company, issuer of the USDC stablecoin and a leader
SoftBank Group Corp. has sold its complete stake in Nvidia Corp. for $5.83 billion, a bold divestment announced on November 11, 2025, as the Japanese tech investor shifts capital toward new AI ventures. The sale of 32.1 million Nvidia shares,
Nebius Group N.V. (NASDAQ: NBIS) released its third-quarter 2025 financial results on November 11, 2025, reporting revenue that fell short of analyst expectations but unveiling a massive $3 billion AI infrastructure partnership with Meta Platforms that has captured investor attention.
Pfizer Inc. (NYSE: PFE) shares rose 2% on November 10, 2025, closing at $24.81 after the pharmaceutical giant announced the $1.7 billion acquisition of Metsera Inc., a promising obesity drug developer, and reported a third-quarter 2025 earnings beat that highlighted
XRP price has shown notable volatility in November 2025, trading around $2.30 to $2.35 amid growing speculation over potential ETF approvals and increased whale transactions. The cryptocurrency, developed by Ripple Labs, has gained attention as Bloomberg analysts estimate a 95%
